Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Embargo

Mar 30, 2017 03:34PM

Mar 30, 2017 04:15PM

Mar 31, 2017 10:31AM

Re: Embargo

Nextblockbuster

Mar 31, 2017 11:27AM

Re: Embargo

BearDownAZ

Mar 31, 2017 11:36AM

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Embargo

in response to

Re: Embargo

BearDownAZ

posted on Mar 31, 2017 12:13PM

BDAZ - From the information gleaned at the 23 Feb Broker meeting http://agoracom.com/ir/ZenithEpigenetics/forums/discussion/topics/686621-broker-meeting-23-feb/messages/2140189#message Zenith had at least one patient that was on the drug for 7 months at that time. There should be something learned from that to talk about. These were apparently pretty sick patients that were being recruited for this trial.